{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:10:38Z","timestamp":1790745038149,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Genetic polymorphisms in the human immune system modulate susceptibility to malaria. However, there is a paucity of data on the contribution of immunogenetic variants to malaria susceptibility in infants, who present differential biological features related to the immaturity of their adaptive immune system, the protective effect of maternal antibodies and fetal haemoglobin. This study investigated the association between genetic variation in innate immune response genes and malaria susceptibility during the first year of life in 656 infants from a birth cohort survey performed in Nanoro, Burkina Faso.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventeen single nucleotide polymorphisms (SNPs) in 11 genes of the immune system previously associated with different malaria phenotypes were genotyped using TaqMan allelic hybridization assays in a Fluidigm platform.<jats:italic>Plasmodium falciparum<\/jats:italic>infection and clinical disease were documented by active and passive case detection. Case\u2013control association analyses for both alleles and genotypes were carried out using univariate and multivariate logistic regression. For cytokines showing significant SNP associations in multivariate analyses, cord blood supernatant concentrations were measured by quantitative suspension array technology (Luminex).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Genetic variants in IL-1\u03b2 (rs1143634) and Fc\u03b3RIIA\/CD32 (rs1801274)\u2014both in allelic, dominant and co-dominant models\u2014were significantly associated with protection from both<jats:italic>P. falciparum<\/jats:italic>infection and clinical malaria. Furthermore, heterozygote individuals with rs1801274 SNP in Fc\u03b3RIIA\/CD32 showed higher IL-1RA levels compared to wild-type homozygotes (<jats:italic>P<\/jats:italic>\u2009=\u20090.024), a cytokine whose production is promoted by the binding of IgG immune complexes to Fc\u03b3 receptors on effector immune cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings indicate that genetic polymorphisms in genes driving innate immune responses are associated to malaria susceptibility during the first year of life, possibly by modulating production of inflammatory mediators.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12936-021-03628-y","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T17:17:14Z","timestamp":1613582234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genetic variation in the immune system and malaria susceptibility in infants: a nested case\u2013control study in Nanoro, Burkina Faso"],"prefix":"10.1186","volume":"20","author":[{"given":"Hamatandi Magloire","family":"Natama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Rovira-Vallbona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Krit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Guetens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Sorgho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Athanase","family":"Som\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maminata","family":"Traor\u00e9-Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Val\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra F.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk D. F. H.","family":"Schallig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Berkvens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Kestens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-5203","authenticated-orcid":false,"given":"Anna","family":"Rosanas-Urgell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"3628_CR1","volume-title":"World malaria report 2016","author":"WHO","year":"2016","unstructured":"WHO. World malaria report 2016. Geneva: World Health Organization; 2016."},{"key":"3628_CR2","volume-title":"World malaria report 2017","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization; 2017."},{"key":"3628_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0959-437X(96)80013-X","volume":"6","author":"AV Hill","year":"1996","unstructured":"Hill AV. Genetics of infectious disease resistance. Curr Opin Genet Dev. 1996;6:348\u201353.","journal-title":"Curr Opin Genet Dev"},{"key":"3628_CR4","doi-asserted-by":"publisher","first-page":"940616","DOI":"10.1155\/2012\/940616","volume":"2012","author":"VRR de Mendon\u00e7a","year":"2012","unstructured":"de Mendon\u00e7a VRR, Goncalves MS, Barral-Netto M. The host genetic diversity in malaria infection. J Trop Med. 2012;2012:940616.","journal-title":"J Trop Med"},{"key":"3628_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1371\/journal.pmed.0020340","volume":"2","author":"MJ Mackinnon","year":"2005","unstructured":"Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN. Heritability of malaria in Africa. PLoS Med. 2005;2:1253\u20139.","journal-title":"PLoS Med"},{"key":"3628_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1475-2875-10-271","volume":"10","author":"A Driss","year":"2011","unstructured":"Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK. Genetic polymorphisms linked to susceptibility to malaria. Malar J. 2011;10:271.","journal-title":"Malar J"},{"key":"3628_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.meegid.2017.06.001","volume":"66","author":"S Marquet","year":"2018","unstructured":"Marquet S. Overview of human genetic susceptibility to malaria: From parasitemia control to severe disease. Infect Genet Evol. 2018;66:399\u2013409.","journal-title":"Infect Genet Evol"},{"key":"3628_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/352595a0","volume":"352","author":"AV Hill","year":"1991","unstructured":"Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common West African HLA antigens are associated with protection from severe malaria. Nature. 1991;352:595\u2013600.","journal-title":"Nature"},{"key":"3628_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1086\/317642","volume":"183","author":"J May","year":"2001","unstructured":"May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections. J Infect Dis. 2001;183:168\u201372.","journal-title":"J Infect Dis"},{"issue":"12","key":"3628_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/hmg\/ddg033","volume":"15","author":"L Flori","year":"2003","unstructured":"Flori L. Linkage of mild malaria to the major histocompatibility complex in families living in Burkina Faso. Hum Mol Genet. 2003;15(12):375\u20138.","journal-title":"Hum Mol Genet"},{"key":"3628_CR11","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1128\/IAI.00261-12","volume":"10","author":"G Zhang","year":"2012","unstructured":"Zhang G, Manaca MN, McNamara-Smith M, Mayor A, Nhabomba A, Berthoud TK, et al. IL-10 polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun. 2012;10:2316\u201322.","journal-title":"Infect Immun"},{"key":"3628_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1086\/314533","volume":"179","author":"W McGuire","year":"1999","unstructured":"McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis. 1999;179:287\u201390.","journal-title":"J Infect Dis"},{"key":"3628_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1086\/432484","volume":"192","author":"S Cabantous","year":"2005","unstructured":"Cabantous S, Poudiougou B, Traore A, Keita M, Cisse MB, Doumbo O, et al. Evidence that interferon-gamma plays a protective role during cerebral malaria. J Infect Dis. 2005;192:854\u201360.","journal-title":"J Infect Dis"},{"key":"3628_CR14","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1086\/340516","volume":"185","author":"O Koch","year":"2002","unstructured":"Koch O, Awomoyi A, Usen S, Jallow M, Richardson A, Hull J, et al. IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J Infect Dis. 2002;185:1684\u20137.","journal-title":"J Infect Dis"},{"key":"3628_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.gene.6363962","volume":"4","author":"C Aucan","year":"2003","unstructured":"Aucan C, Walley AJ, Hennig BJW, Fitness J, Frodsham A, Zhang L, et al. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 2003;4:275\u201382.","journal-title":"Genes Immun"},{"key":"3628_CR16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.meegid.2011.05.021","volume":"11","author":"E Israelsson","year":"2011","unstructured":"Israelsson E, Maiga B, Kearsley S, Dolo A, Homann MV, Doumbo OK, et al. Cytokine gene haplotypes with a potential effect on susceptibility to malaria in sympatric ethnic groups in Mali. Infect Genet Evol. 2011;11:1608\u201315.","journal-title":"Infect Genet Evol"},{"key":"3628_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1073\/pnas.0506803102","volume":"103","author":"FP Mockenhaupt","year":"2006","unstructured":"Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh N-R, et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci USA. 2006;103:177\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3628_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1475-2875-11-196","volume":"11","author":"S Esposito","year":"2012","unstructured":"Esposito S, Molteni CG, Zampiero A, Baggi E, Lavizzari A, Semino M, et al. Role of polymorphisms of toll-like receptor ( TLR ) containing adaptor protein ( TIRAP ) and FCGR2A genes in malaria susceptibility and severity in Burundian children. Malar J. 2012;11:196.","journal-title":"Malar J"},{"key":"3628_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1475-2875-11-168","volume":"11","author":"AH Omar","year":"2012","unstructured":"Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD, et al. Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. Malar J. 2012;11:168.","journal-title":"Malar J"},{"key":"3628_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1475-2875-11-47","volume":"11","author":"JA Greene","year":"2012","unstructured":"Greene JA, Sam-Agudu N, John CC, Opoka RO, Zimmerman PA, Kazura JW. Toll-like receptor polymorphisms and cerebral malaria: TLR2 \u039422 polymorphism is associated with protection from cerebral malaria in a case control study. Malar J. 2012;11:47.","journal-title":"Malar J"},{"key":"3628_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1473-3099(05)01308-3","volume":"5","author":"NWJ Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der NWJ, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis. 2005;5:156\u201364.","journal-title":"Lancet Infect Dis"},{"key":"3628_CR22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1172\/JCI116022","volume":"90","author":"PW Parren","year":"1992","unstructured":"Parren PW, Warmerdam PA, Boeije LC, Arts J, Westerdaal NA, Vlug A, et al. On the interaction of IgG subclasses with the low affinity FcyRlla ( CD 32) on human monocytes, neutrophils, and platelets: analysis of a functional polymorphism to human IgG 2. J Clin Invest. 1992;90:1537\u201346.","journal-title":"J Clin Invest"},{"key":"3628_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1475-2875-7-175","volume":"7","author":"E Israelsson","year":"2008","unstructured":"Israelsson E, Vafa M, Maiga B, Lys\u00e9n A, Iriemenam NC, Dolo A, et al. Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali. Malar J. 2008;7:175.","journal-title":"Malar J"},{"key":"3628_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1383-5769(02)00040-5","volume":"51","author":"K Omi","year":"2002","unstructured":"Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, et al. Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int. 2002;51:361\u20136.","journal-title":"Parasitol Int"},{"key":"3628_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1086\/320999","volume":"184","author":"YP Shi","year":"2001","unstructured":"Shi YP, Nahlen BL, Kariuki S, Urdahl KB, McElroy PD, Roberts JM, et al. Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J Infect Dis. 2001;184:107\u201311.","journal-title":"J Infect Dis"},{"key":"3628_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.4269\/ajtmh.2006.74.573","volume":"74","author":"C Ouma","year":"2006","unstructured":"Ouma C, Keller CC, Opondo DA, Were T, Otieno RO, Otieno MF, et al. Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. Am J Trop Med Hyg. 2006;74:573\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"3628_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/sj.gene.6364231","volume":"6","author":"L Flori","year":"2005","unstructured":"Flori L, Delahaye NF, Iraqi FA, Fumoux F, Rihet P. TNF as a malaria candidate gene\u202f: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso. Genes Immun. 2005;6:472\u201380.","journal-title":"Genes Immun"},{"key":"3628_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.2003.69.565","volume":"69","author":"GS Cooke","year":"2003","unstructured":"Cooke GS, Aucan C, Walley AJ, Segal S, Greenwood BM, Kwiatkowski DP, et al. Association of Fc\u03b3 receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg. 2003;69:565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"3628_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.actatropica.2014.09.019","volume":"142","author":"MK Cherif","year":"2015","unstructured":"Cherif MK, Sanou GS, Bougouma EC, Diarra A, Ouedraogo A, Dolo A, et al. Is Fc gamma receptor IIA (Fc gamma RIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso? Acta Trop. 2015;142:41\u20136.","journal-title":"Acta Trop"},{"key":"3628_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12936-018-2315-4","volume":"17","author":"HM Natama","year":"2018","unstructured":"Natama HM, Vallbona ER, Som\u00e9 MA, Zango SH, Sorgho H, Guetens P, et al. Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study. Malar J. 2018;17:163.","journal-title":"Malar J"},{"key":"3628_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4269\/ajtmh.1998.58.211","volume":"58","author":"OH Branch","year":"1998","unstructured":"Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, et al. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg. 1998;58:211\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"3628_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2249.1997.tb08319.x","volume":"110","author":"P Deloron","year":"1997","unstructured":"Deloron P, Dubois B, Le Hesran JY, Riche D, Fievet N, Cornet M, et al. Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol. 1997;110:212\u20138.","journal-title":"Clin Exp Immunol"},{"key":"3628_CR33","doi-asserted-by":"publisher","first-page":"e14798","DOI":"10.1371\/journal.pone.0014798","volume":"6","author":"C Amaratunga","year":"2011","unstructured":"Amaratunga C, Lopera-Mesa TM, Brittain NJ, Cholera R, Arie T, Fujioka H, et al. A role for fetal hemoglobin and maternal immune IgG in infant resistance to Plasmodium falciparum malaria. PLoS ONE. 2011;6:e14798.","journal-title":"PLoS ONE"},{"key":"3628_CR34","doi-asserted-by":"publisher","first-page":"e107965","DOI":"10.1371\/journal.pone.0107965","volume":"9","author":"DT Kangoye","year":"2014","unstructured":"Kangoye DT, Nebie I, Yaro JB, Debe S, Traore S, Ouedraogo O, et al. Plasmodium falciparum malaria in children aged 0\u20132 Years: The role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP). PLoS ONE. 2014;9:e107965.","journal-title":"PLoS ONE"},{"issue":"282","key":"3628_CR35","first-page":"3085","volume":"2015","author":"AK Simon","year":"2014","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Soc Biol. 2014;2015(282):3085.","journal-title":"Proc Soc Biol"},{"key":"3628_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12916-018-1187-3","volume":"18","author":"HM Natama","year":"2018","unstructured":"Natama HM, Moncunill G, Rovira-vallbona E, Sanz H, Sorgho H, Aguilar R, et al. Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life. BMC Med. 2018;18:198.","journal-title":"BMC Med"},{"key":"3628_CR37","doi-asserted-by":"publisher","first-page":"ofv012","DOI":"10.1093\/ofid\/ofv012","volume":"2","author":"T Apinjoh","year":"2015","unstructured":"Apinjoh T, Anchang-Kimbi J, Mugri R, Njua-Yafi C, Tata R, Chi H, et al. Determinants of infant susceptibility to malaria during the first year of life in South Western Cameroon. Open Forum Infect Dis. 2015;2:ofv012.","journal-title":"Open Forum Infect Dis"},{"key":"3628_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-3156.1996.d01-89.x","volume":"1","author":"AY Kitua","year":"1996","unstructured":"Kitua AY, Smith T, Alonso PL, Masanja H, Urassa H, Menendez C, et al. Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Trop Med Int Health. 1996;1:475\u201384.","journal-title":"Trop Med Int Health"},{"key":"3628_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.immunol.16.1.593","volume":"16","author":"AV Hill","year":"1998","unstructured":"Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol. 1998;16:593\u2013617.","journal-title":"Annu Rev Immunol"},{"key":"3628_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.meegid.2014.02.011","volume":"23","author":"J Zhao","year":"2014","unstructured":"Zhao J, Ma L, Chen S, Xie Y, Xie L, Deng Y, et al. Association between Fc-gamma receptor IIa (CD32) gene polymorphism and malaria susceptibility: a meta-analysis based on 6928 subjects. Infect Genet Evol. 2014;23:169\u201375.","journal-title":"Infect Genet Evol"},{"key":"3628_CR41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/IAI.00671-15","volume":"84","author":"S Marquet","year":"2016","unstructured":"Marquet S, Conte I, Poudiougou B, Argiro L, Cabantous S, Dessein H, et al. The IL17F and IL17RA genetic variants increase risk of cerebral malaria in two African populations. Infect Immun. 2016;84:590\u20137.","journal-title":"Infect Immun"},{"key":"3628_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.meegid.2010.05.005","volume":"10","author":"L Hamann","year":"2010","unstructured":"Hamann L, Bedu-Addo G, Eggelte TA, Schumann RR, Mockenhaupt FP. The toll-like receptor 1 variant S248N influences placental malaria. Infect Genet Evol. 2010;10:785\u20139.","journal-title":"Infect Genet Evol"},{"key":"3628_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1745-6215-15-340","volume":"15","author":"S Scott","year":"2014","unstructured":"Scott S, Mens PF, Tinto H, Nahum A, Ruizendaal E, Pagnoni F, et al. Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial. Trials. 2014;15:340.","journal-title":"Trials"},{"key":"3628_CR44","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/infdis\/jiy140","volume":"217","author":"HM Natama","year":"2018","unstructured":"Natama HM, Rovira-Vallbona E, Sorgho H, Som\u00e9 MA, Traor\u00e9-Coulibaly M, Scott S, et al. Additional screening and treatment of malaria during pregnancy provides further protection against malaria and nonmalarial fevers during the first year of life. J Infect Dis. 2018;217:1967\u201376.","journal-title":"J Infect Dis"},{"key":"3628_CR45","volume-title":"Basic malaria microscopy: Part I Learner\u2019s Guide","author":"WHO","year":"2010","unstructured":"WHO. Basic malaria microscopy: Part I Learner\u2019s Guide. 2nd ed. Geneva: World Health Organization; 2010.","edition":"2"},{"key":"3628_CR46","doi-asserted-by":"publisher","first-page":"e1001788","DOI":"10.1371\/journal.pmed.1001788","volume":"12","author":"N Hofmann","year":"2015","unstructured":"Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12:e1001788.","journal-title":"PLoS Med"},{"key":"3628_CR47","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/s41598-017-02173-6","volume":"7","author":"HM Natama","year":"2017","unstructured":"Natama HM, Ouedraogo DF, Sorgho H, Rovira-Vallbona E, Serra-casas E, Som\u00e9 MA, et al. Diagnosing congenital malaria in a high-transmission setting\u202f: clinical relevance and usefulness of P. falciparum HRP2-based testing. Sci Rep. 2017;7:2080.","journal-title":"Sci Rep"},{"key":"3628_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1373\/49.6.853","volume":"860","author":"CT Wittwer","year":"2003","unstructured":"Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem. 2003;860:853\u201360.","journal-title":"Clin Chem"},{"key":"3628_CR49","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2016","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016."},{"key":"3628_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mgene.2015.04.003","volume":"5","author":"N Horita","year":"2015","unstructured":"Horita N, Kaneko T. Genetic model selection for a case-control study and a meta-analysis. Meta Gene. 2015;5:1\u20138.","journal-title":"Meta Gene"},{"key":"3628_CR51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:239\u2013300.","journal-title":"J R Stat Soc"},{"key":"3628_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/clin.1995.1004","volume":"74","author":"DM Chang","year":"1995","unstructured":"Chang DM. Cellular signals for the induction of human interleukin-1 receptor antagonist. Clin Immunol Immunopathol. 1995;74:23\u201330.","journal-title":"Clin Immunol Immunopathol"},{"key":"3628_CR53","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.4049\/jimmunol.147.5.1530","volume":"147","author":"WP Arend","year":"1991","unstructured":"Arend WP, Smith MF, Janson RW, Joslin FG. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. J Immunol. 1991;147:1530\u20136.","journal-title":"J Immunol"},{"key":"3628_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/sji.12122","volume":"79","author":"B Maiga","year":"2014","unstructured":"Maiga B, Dolo A, Tour\u00e9 O, Dara V, Tapily A, Campino S, et al. Fc gamma Receptor IIa-H131R polymorphism and malaria susceptibility in sympatric ethnic groups, Fulani and Dogon of Mali. Scand J Immunol. 2014;79:43\u201350.","journal-title":"Scand J Immunol"},{"key":"3628_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-3083.2007.01947.x","volume":"66","author":"A Nasr","year":"2007","unstructured":"Nasr A, Iriemenam NC, Troye-Blomberg M, Giha HA, Balogun HA, Osman OF, et al. Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients. Scand J Immunol. 2007;66:87\u201396.","journal-title":"Scand J Immunol"},{"key":"3628_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1475-2875-12-110","volume":"12","author":"A Nasr","year":"2013","unstructured":"Nasr A, Hamid O, Al-Ghamdi A, Allam G. Anti-malarial IgG subclasses pattern and Fc\u03b3RIIa (CD32) polymorphism among pregnancy-associated malaria in semi-immune Saudi women. Malar J. 2013;12:110.","journal-title":"Malar J"},{"key":"3628_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2875-7-13","volume":"7","author":"S Sinha","year":"2008","unstructured":"Sinha S, Mishra SK, Sharma S, Patibandla PK, Mallick PK, Sharma SK, et al. Polymorphisms of TNF-enhancer and gene for Fc\u03b3RIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J. 2008;7:13.","journal-title":"Malar J"},{"key":"3628_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12879-017-2390-0","volume":"17","author":"EO Munde","year":"2017","unstructured":"Munde EO, Okeyo WA, Raballah E, Anyona SB, Were T, Ong\u2019echa JM, et al. Association between Fc\u03b3 receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya. BMC Infect Dis. 2017;17:289.","journal-title":"BMC Infect Dis"},{"key":"3628_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1383-5769(02)00040-5","volume":"51","author":"K Omi","year":"2002","unstructured":"Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, et al. Fc\u03b3 receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int. 2002;51:361\u20136.","journal-title":"Parasitol Int"},{"key":"3628_CR60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00439-011-1076-8","volume":"131","author":"C Ouma","year":"2012","unstructured":"Ouma C, Davenport GC, Garcia S, Kempaiah P, Chaudhary A, Were T, et al. Functional haplotypes of Fc gamma (Fc\u03b3) receptor (Fc\u03b3RIIA and Fc\u03b3RIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children. Hum Genet. 2012;131:289\u201399.","journal-title":"Hum Genet"},{"key":"3628_CR61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1471-4922(01)02086-4","volume":"17","author":"RJ Pleass","year":"2001","unstructured":"Pleass RJ, Woof JM. Fc receptors and immunity to parasites. Trends Parasitol. 2001;17:545\u201351.","journal-title":"Trends Parasitol"},{"key":"3628_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0167-5699(93)90166-I","volume":"14","author":"JG van de Winkel","year":"1993","unstructured":"van de Winkel JG, Capel PJ. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today. 1993;14:215\u201321.","journal-title":"Immunol Today"},{"key":"3628_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4172\/1747-0862.1000004","volume":"1","author":"EM Braga","year":"2005","unstructured":"Braga EM, Scopel KKG, Komatsu NT, da Silva-Nunes M, Ferreira MU. Polymorphism of the Fcgamma receptor IIA and malaria morbidity. J Mol Genet Med. 2005;1:5\u201310.","journal-title":"J Mol Genet Med"},{"key":"3628_CR64","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4049\/jimmunol.147.4.1338","volume":"147","author":"PA Warmerdam","year":"1991","unstructured":"Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol. 1991;147:1338\u201343.","journal-title":"J Immunol"},{"key":"3628_CR65","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cyto.2007.12.008","volume":"41","author":"CC John","year":"2008","unstructured":"John CC, Park GS, Sam-Agudu N, Opoka RO, Boivin MJ. Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine. 2008;41:204\u20138.","journal-title":"Cytokine"},{"key":"3628_CR66","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1128\/iai.62.10.4374-4379.1994","volume":"62","author":"PH Jakobsen","year":"1994","unstructured":"Jakobsen PH, McKay V, Morris-Jones SD, McGuire W, Van Hensbroek MB, Meisner S, et al. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. Infect Immun. 1994;62:4374\u20139.","journal-title":"Infect Immun"},{"key":"3628_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1475-2875-6-147","volume":"6","author":"HB Armah","year":"2007","unstructured":"Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J. 2007;6:147.","journal-title":"Malar J"},{"key":"3628_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pt.2013.12.007","volume":"30","author":"R Ata\u00edde","year":"2014","unstructured":"Ata\u00edde R, Mayor A, Rogerson SJ. Malaria, primigravidae, and antibodies: Knowledge gained and future perspectives. Trends Parasitol. 2014;30:85\u201394.","journal-title":"Trends Parasitol"},{"key":"3628_CR69","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1084\/jem.173.4.931","volume":"173","author":"KW McIntyre","year":"1991","unstructured":"McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, et al. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med. 1991;173:931\u20139.","journal-title":"J Exp Med"},{"key":"3628_CR70","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1046\/j.1365-3083.2002.01161.x","volume":"56","author":"B Gyan","year":"2002","unstructured":"Gyan B, Goka B, Cvetkovic JT, Perlmann H, Lefvert AK, Akanmori B, et al. Polymorphisms in interleukin-1 \u03b2 and interleukin-1 receptor antagonist genes and malaria in Ghanaian children. Scand J Immunol. 2002;56:619\u201322.","journal-title":"Scand J Immunol"},{"key":"3628_CR71","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/sj.ejhg.5201084","volume":"12","author":"AJ Walley","year":"2004","unstructured":"Walley AJ, Aucan C, Kwiatkowski D, Hill AV. Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet. 2004;12:132\u20138.","journal-title":"Eur J Hum Genet"},{"key":"3628_CR72","doi-asserted-by":"publisher","first-page":"e81071","DOI":"10.1371\/journal.pone.0081071","volume":"8","author":"TO Apinjoh","year":"2013","unstructured":"Apinjoh TO, Anchang-Kimbi JK, Njua-Yafi C, Mugri RN, Ngwai AN, Rockett KA, et al. Association of cytokine and toll-like receptor gene polymorphisms with severe malaria in three regions of cameroon. PLoS ONE. 2013;8:e81071.","journal-title":"PLoS ONE"},{"key":"3628_CR73","first-page":"201","volume":"10","author":"CA Dinarello","year":"2004","unstructured":"Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004;10:201\u201322.","journal-title":"J Endotoxin Res"},{"key":"3628_CR74","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/330664a0","volume":"330","author":"L Schofield","year":"1987","unstructured":"Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987;330:664\u20136.","journal-title":"Nature"},{"key":"3628_CR75","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/eji.1830220914","volume":"22","author":"SGS Vreden","year":"1992","unstructured":"Vreden SGS, Van den Broek MF, Oettinger MC, Verhave JP, Meuwissen JHET, Sauerwein RW. Cytokines inhibit the development of liver schizonts of the malaria parasite Plasmodium berghei in vivo. Eur J Immunol. 1992;22:2271\u20135.","journal-title":"Eur J Immunol"},{"key":"3628_CR76","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/504720","volume":"194","author":"D Prakash","year":"2006","unstructured":"Prakash D, Fesel C, Jain R, Cazenave P-A, Mishra GC, Pied S. Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis. 2006;194:198\u2013207.","journal-title":"J Infect Dis"},{"key":"3628_CR77","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1365-3156.2004.01265.x","volume":"9","author":"A Vogetseder","year":"2004","unstructured":"Vogetseder A, Ospelt C, Reindl M, Schober M, Schmutzhard E. Time course of coagulation parameters, cytokines and adhesion molecules in Plasmodium falciparum malaria. Trop Med Int Health. 2004;9:767\u201373.","journal-title":"Trop Med Int Health"},{"key":"3628_CR78","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/506623","volume":"194","author":"CC John","year":"2006","unstructured":"John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis. 2006;194:837\u201345.","journal-title":"J Infect Dis"},{"key":"3628_CR79","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2362.1992.tb01480.x","volume":"22","author":"F Pociot","year":"1992","unstructured":"Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1\u03b2 (IL-1\u03b2) gene correlates with IL-1\u03b2 secretion in vitro. Eur J Clin Invest. 1992;22:396\u2013402.","journal-title":"Eur J Clin Invest"},{"key":"3628_CR80","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/molehr\/gag076","volume":"9","author":"C Hernandez-Guerrero","year":"2003","unstructured":"Hernandez-Guerrero C, Monzon-Bordonaba F, Jimenez-Zamudio L, Ahued-Ahued R, Arechavaleta-Velasco F, Strauss JF, et al. In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-\u03b1 and interleukin-1\u03b2. Mol Hum Reprod. 2003;9:625\u20139.","journal-title":"Mol Hum Reprod"},{"key":"3628_CR81","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1086\/592055","volume":"198","author":"C Ouma","year":"2008","unstructured":"Ouma C, Davenport GC, Awandare GA, Keller CC, Were T, Otieno MF, et al. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. J Infect Dis. 2008;198:1219\u201326.","journal-title":"J Infect Dis"},{"key":"3628_CR82","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/hmg\/ddi469","volume":"15","author":"H Chen","year":"2006","unstructured":"Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006;15:519\u201329.","journal-title":"Hum Mol Genet"},{"key":"3628_CR83","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","volume":"47","author":"S Santtila","year":"1998","unstructured":"Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47:195\u20138.","journal-title":"Scand J Immunol"},{"key":"3628_CR84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00439-008-0488-6","volume":"123","author":"J Rogus","year":"2008","unstructured":"Rogus J, Beck JD, Offenbacher S, Huttner K, Iacoviello L, Latella MC, et al. IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet. 2008;123:387\u201398.","journal-title":"Hum Genet"},{"key":"3628_CR85","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","volume":"180","author":"KN Couper","year":"2008","unstructured":"Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771\u20137.","journal-title":"J Immunol"},{"key":"3628_CR86","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/clin.1995.1017","volume":"74","author":"C Wenisch","year":"1995","unstructured":"Wenisch C. Elevated serum levels of IL-10 and IFN-\u03b3 in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol. 1995;74:115\u20137.","journal-title":"Clin Immunol Immunopathol"},{"key":"3628_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.0141-9838.2004.00678.x","volume":"26","author":"E Hugosson","year":"2004","unstructured":"Hugosson E, Montgomery SM, Premji Z, Troye-Blomberg M, Bj\u00f6rkman A. Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol. 2004;26:111\u20137.","journal-title":"Parasite Immunol"},{"key":"3628_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1179\/2047773212Y.0000000069","volume":"107","author":"MK Perera","year":"2013","unstructured":"Perera MK, Herath NP, Pathirana SL, Phone-Kyaw M, Alles HK, Mendis KN, et al. Association of high plasma TNF-alpha levels and TNF-alpha\/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka. Pathog Glob Health. 2013;107:21\u20139.","journal-title":"Pathog Glob Health."},{"key":"3628_CR89","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1475-2875-11-253","volume":"11","author":"PS Boeuf","year":"2012","unstructured":"Boeuf PS, Loizon S, Awandare GA, Tetteh JK, Addae MM, Adjei GO, et al. Insights into deregulated TNF and IL-10 production in malaria: Implications for understanding severe malarial anaemia. Malar J. 2012;11:253.","journal-title":"Malar J"},{"key":"3628_CR90","doi-asserted-by":"publisher","first-page":"e1003864","DOI":"10.1371\/journal.ppat.1003864","volume":"10","author":"P Jagannathan","year":"2014","unstructured":"Jagannathan P, Eccles-James I, Bowen K, Nankya F, Auma A, Wamala S, et al. IFN\u03b3\/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog. 2014;10:e1003864.","journal-title":"PLoS Pathog"},{"key":"3628_CR91","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2249.1994.tb06527.x","volume":"95","author":"F Peyron","year":"1994","unstructured":"Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, Banchereau J. High levels of circulating IL-10 in human malaria. Clin Exp Immunol. 1994;95:300\u20133.","journal-title":"Clin Exp Immunol"},{"key":"3628_CR92","doi-asserted-by":"publisher","first-page":"e47463","DOI":"10.1371\/journal.pone.0047463","volume":"7","author":"A Manjurano","year":"2012","unstructured":"Manjurano A, Clark TG, Nadjm B, Mtove G, Wangai H, Sepulveda N, et al. Candidate human genetic polymorphisms and severe malaria in a Tanzanian population. PLoS ONE. 2012;7:e47463.","journal-title":"PLoS ONE"},{"key":"3628_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s1678-9946201658030","volume":"58","author":"W Domingues","year":"2016","unstructured":"Domingues W, Kanunfre KA, Rodrigues JC, Teixeira LE, Yamamoto L, Okay TS. Preliminary report on the putative association of IL10 -3575 T\/A genetic polymorphism with malaria symptoms. Rev Inst Med Trop Sao Paulo. 2016;58:1\u201310.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"3628_CR94","doi-asserted-by":"publisher","first-page":"e36692","DOI":"10.1371\/journal.pone.0036692","volume":"7","author":"SS Da Silva","year":"2012","unstructured":"Da Silva SS, Clark TG, Campino S, Suarez-Mutis MC, Rockett KA, Kwiatkowski DP, et al. Investigation of host candidate malaria-associated risk\/protective SNPs in a Brazilian Amazonian population. PLoS ONE. 2012;7:e36692.","journal-title":"PLoS ONE"},{"key":"3628_CR95","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ebiom.2017.09.037","volume":"25","author":"ID Legason","year":"2017","unstructured":"Legason ID, Pfeiffer RM, Udquim KI, Bergen AW, Gouveia MH, Kirimunda S, et al. Evaluating the causal link between malaria infection and endemic Burkitt Lymphoma in Northern Uganda: a Mendelian randomization study. EbioMedicine. 2017;25:58\u201365.","journal-title":"EbioMedicine"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-021-03628-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T09:48:23Z","timestamp":1724492903000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-021-03628-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3628"],"URL":"https:\/\/doi.org\/10.1186\/s12936-021-03628-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from mothers during antenatal care visits prior to delivery. The study received ethical approvals from the institutional ethics committees of Centre Muraz, Bobo Dioulasso, Burkina Faso (006-2014\/CE-CM), the Institute of Tropical Medicine, Antwerp, Belgium (953\/14), and University Hospital in Antwerp, Belgium (14\/26\/277).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}